JULY 2024LIFE SCIENCES REVIEW5Prue Cowin B.BiomedSci (Hons) PhD,Senior Associate,Patent Attorney, FB Rice andDr Sarah Tregenza BSc(Hons) PhD,APAC Oncology Medical Affairs Director,Pierre Fabre GroupKey Considerations for the Evolving Cell Therapy Landscape20Marianthi Psacha, President,Santen PharmaceuticalHow we're Leveraging New Technological Advancements by Building a Cell & Gene Therapy Business unit within an Established Pharmaceutical Company19Dae Wook Lee, Medicine (MbChB), MBA, MSC, BSc,Medical Director and Medical Franchise Head for CRM, Neuroscience, and Gene Therapy,Novartis Pharmaceuticals KoreaBiotechnology with the Latest Advancement and Innovation22Haichen Yang, MD, MA, MBA,Vice President,Clinical Research,Amicus Therapeutics Inc.Challenges and opportunities in gene therapy clinical development26Rachel Legmann, PhD,Senior Director of Technology,Gene Therapy,Repligen CorpGene Therapy--Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation28FEATURED COMPANYCXO INSIGHTSCXO INSIGHTSTara Moroz, PhD,Sr. Director, Global Medical Communications and Content | Specialty Care, Rare Disease,Pfizer, Inc.Gene Therapy Clearly Communicated: The Importance of Patient-Centricity, An Omnichannel Approach, and Health Literacy24CELL ANDGENE THERAPYCOMPANIES IN APAC - 2024TOP 10Miss Tharada Thitapurim, COO16Vaanaa Longevity CenterDr. Sarisa Klomchitcharoen,MD, CEO and Medical Director
< Page 4 | Page 6 >